Antibody responses to Campylobacter infections determined by an enzyme-linked immunosorbent assay:: 2-year follow-up study of 210 patients

被引:52
作者
Strid, MA
Engberg, J
Larsen, LB
Begtrup, K
Molbak, K
Krogfelt, KA
机构
[1] Statens Serum Inst, Dept Gastrointestinal Infect, Div Diagnost, DK-2300 Copenhagen S, Denmark
[2] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark
关键词
D O I
10.1128/CDLI.8.2.314-319.2001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
An enzyme-linked immunosorbent assay (ELISA) was adapted to measure immunoglobulin G (IgG), IgM, and IgA classes of human serum antibody to Campylobacter jejuni and Campylobacter coli. Heat stable antigen, a combination of C. jejuni serotype O:1,44 and O:53 in the ratio 1:1, was used as a coating antigen in the ELISA test. A total of 631 sera from 210 patients with verified Campylobacter enteritis were examined at various intervals after infection, and a control group of 164 sera were tested to determine the cut-off for negative results. With a 90th percentile of specificity, IgG, IgM, and IgA showed a sensitivity of 71, 60, and 80%, respectively. By combining all three antibody classes, the sensitivity was 92% within 35 days after infection, whereas within 90 days after infection, a combined sensitivity of 90% was found (IgG 68%, IgM 52%, and IgA 76%). At follow-up of the patients, IgG antibodies were elevated 4.5 months after infection but exhibited a large degree of variation in antibody decay profiles. IgA and IgM antibodies were elevated during the acute phase of infection (up to 2 months from onset of infection). The antibody response did not depend on Campylobacter species or C. jejuni serotype, with the important exception of response to C. jejuni O:19, the serotype most frequently associated with Guillain-Barre syndrome. All of the patients infected with this serotype had higher levels of both IgM (P = 0.006) and IgA (P = 0.06) compared with other C. jejuni and C, coli serotypes.
引用
收藏
页码:314 / 319
页数:6
相关论文
共 26 条
[1]   Campylobacter jejuni strains from patients with Guillain-Barre syndrome [J].
Allos, BM ;
Lippy, FT ;
Carlsen, A ;
Washburn, RG ;
Blaser, MJ .
EMERGING INFECTIOUS DISEASES, 1998, 4 (02) :263-268
[2]  
ANDERSEN LP, 1991, P 5 INT WORKSH CAMP, P221
[3]   HUMAN-SERUM ANTIBODY-RESPONSE TO CAMPYLOBACTER-JEJUNI INFECTION AS MEASURED IN AN ENZYME-LINKED IMMUNOSORBENT-ASSAY [J].
BLASER, MJ ;
DUNCAN, DJ .
INFECTION AND IMMUNITY, 1984, 44 (02) :292-298
[4]   SEROLOGIC STUDY OF 2 CLUSTERS OF INFECTION DUE TO CAMPYLOBACTER-JEJUNI [J].
BLASER, MJ ;
DUNCAN, DJ ;
OSTERHOLM, MT ;
ISTRE, GR ;
WANG, WL .
JOURNAL OF INFECTIOUS DISEASES, 1983, 147 (05) :820-823
[5]   SEROLOGICAL CROSS-REACTION BETWEEN LEGIONELLA-PNEUMOPHILA AND CAMPYLOBACTER IN THE INDIRECT FLUORESCENT-ANTIBODY TEST [J].
BOSWELL, TCJ ;
KUDESIA, G .
EPIDEMIOLOGY AND INFECTION, 1992, 109 (02) :291-295
[6]  
BRONDSTED T, 2000, ANNUAL REPORT ZOONOS, P20
[7]  
Diggle P. J., 2002, ANAL LONGITUDINAL DA
[8]  
Engberg J, 2000, J CLIN MICROBIOL, V38, P286
[9]   Evaluation of antibodies reactive with Campylobacter jejuni in Egyptian diarrhea patients [J].
Ismail, TF ;
Wasfy, MO ;
Oyofo, BA ;
Mansour, MM ;
ElBerry, HM ;
Churilla, AM ;
Eldin, SS ;
Peruski, LF .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1997, 4 (05) :536-539
[10]  
KALDOR J, 1983, J CLIN MICROBIOL, V18, P1